Valuation : Krka, d. d.

Market Cap 8.05B 9.35B 7.55B 6.89B 12.99B 893B 13.03B 89.59B 34.95B 451B 35.09B 34.33B 1,495B P/E 2026 *
19.2x
P/E 2027 * 18.3x
Enterprise Value 7.38B 8.57B 6.92B 6.32B 11.91B 819B 11.94B 82.13B 32.05B 413B 32.17B 31.47B 1,371B EV / Sales 2026 *
3.41x
EV / Sales 2027 * 3.21x
Free-Float
74.74%
Yield 2026 *
3.76%
Yield 2027 * 3.85%
1 day+0.19%
Current month+0.19%
1 month-1.14%
3 months+2.36%
6 months+12.07%
Current year+28.08%
1 week 257.5
Extreme 257.5
267
1 month 257.5
Extreme 257.5
267
Current year 202
Extreme 202
270
1 year 174
Extreme 174
270
3 years 103
Extreme 103
270
5 years 80
Extreme 80
270
10 years 48.01
Extreme 48.01
270
Manager TitleAgeSince
Chief Executive Officer 71 01/01/2005
Director of Finance/CFO - 01/01/2026
Chief Tech/Sci/R&D Officer - 01/03/2023
Director TitleAgeSince
Director/Board Member 59 01/01/2005
Director/Board Member 59 01/01/2005
Director/Board Member 73 01/01/2010
Change 5-day change 1-year change 3-year change Capi.($)
+0.19%0.00%+29.35%+150.00% 9.35B
+3.38%+3.92%+26.96%+78.55% 48.2B
+0.66%+0.33%+54.40%+120.88% 39.97B
-2.49%+5.21%+17.18%+85.56% 12.43B
-1.00%-2.00%-11.21%+12.05% 12.03B
-1.57%-1.28%+25.69%+49.12% 7.75B
-1.39%+3.74%+28.71%+223.40% 7.43B
-0.26%+0.27%+43.89%-11.26% 7.22B
-0.53%-1.53%-36.09%+17.02% 5.3B
+1.26%+0.61%+46.90%+108.52% 4.65B
Average -0.18%+1.86%+22.58%+83.38% 15.43B
Weighted average by Cap. +0.82%+1.31%+29.70%+89.30%

Financials

2026 *2027 *
Net sales 2.16B 2.51B 2.03B 1.85B 3.49B 240B 3.5B 24.06B 9.39B 121B 9.43B 9.22B 402B 2.29B 2.66B 2.15B 1.96B 3.69B 254B 3.71B 25.48B 9.94B 128B 9.98B 9.76B 425B
Net income 427M 495M 400M 365M 688M 47.32B 690M 4.75B 1.85B 23.89B 1.86B 1.82B 79.2B 449M 521M 421M 384M 723M 49.76B 726M 4.99B 1.95B 25.12B 1.95B 1.91B 83.29B
Net Debt -670M -778M -628M -573M -1.08B -74.31B -1.08B -7.45B -2.91B -37.51B -2.92B -2.86B -124B -708M -821M -664M -606M -1.14B -78.5B -1.14B -7.87B -3.07B -39.63B -3.08B -3.02B -131B
Logo Krka, d. d.
Krka dd Novo Mesto is a Slovenia-based company engaged in the production of pharmaceutical preparations. The Company operates through four segments: Prescription Pharmaceuticals that includes medicines for the treatment of cardiovascular diseases, alimentary tract and metabolism and drugs for diseases of the central nervous system, among others; Non-prescription Products, providing vitamins and minerals, cough and cold products, analgesics, sore throat products, among others; Animal Health Products, which offers general anti-infectives and antiparasitics for animals; Health Resort and Tourist Services consisting of Spa resorts in Smarjeske Toplice, Dolenjske Toplice, Strunjan, Novo Mesto and Otocec. Krka dd Novo Mesto is a controlling company of the Krka Group that includes two subsidiaries in Slovenia, Terme Krka doo and Farma GRS doo, and over 20 subsidiaries abroad in such countries as Croatia, Germany, Sweden, Poland, Spain, United States, Ireland, among others.
Employees
13,300
Date Price Change Volume
28/08/26 €266.00 0.00% 1,433
27/08/26 €266.00 +1.53% 2,752
26/08/26 €262.00 +0.77% 4,037
25/08/26 €260.00 +0.97% 4,435
24/08/26 €257.50 -0.96% 3,866
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
266.00EUR
Average target price
245.65EUR
Spread / Average Target
-7.65%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KRKG Stock